Hyoung Jin Kang, MD, PhD, associate professor, Department of Pediatrics, Seoul National University, South Korea, discusses a phase III trial of aprepitant for chemotherapy-induced nausea and vomiting (CINV) in children.
Hyoung Jin Kang, MD, PhD
Advertisement
Articles by Hyoung Jin Kang, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Nurses Advised: ASCO Cautions Against Ivermectin and Fenbendazole Use
2
Daraxonrasib Nearly Doubles Survival in Pancreatic Cancer: What Nurses Need to Know
3
Daraxonrasib in Pancreatic Cancer: What Oncology Nurses Need to Know
4
Managing Erectile Dysfunction in Prostate Cancer
5